Discover
REVB
Revelation Biosciences, Inc.
1.04
2 x 0.76
2 x 1.34
bid
ask
+
0.01
0.97%
2 @ 04:00 PM
1.05 +0.01 (0.96%)
| Ytd | -67.50% | |
| 1y | -89.43% |
1.02
day range
1.06
0.88
52 week range
12.88
| Open | 1.02 | Prev Close | 1.03 | Low | 1.02 | High | 1.06 | Mkt Cap | 4.06M |
| Vol | 25.16K | Avg Vol | 61.06K | EPS | -1.32 | P/E | N/A | Forward P/E | -0.13 |
| Beta | 0.15 | Short Ratio | 0.11 | Inst. Own | 8.90% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-07 | 50-d Avg | 1.05 | 200-d Avg | 2.69 | 1yr Est | 12.75 |
Earning
| Date | For | Estimate | Reported | Surprise | surprise % |
|---|---|---|---|---|---|
| 2024-11-08 | 2024-09 | -2.84 | -0.84 | 2 | 70.42% |
| 2024-08-09 | 2024-06 | -1.81 | -1.54 | 0.27 | 14.92% |
| 2024-08-09 | 2024-06 | -1.81 | N/A | N/A | N/A |
| 2024-05-10 | 2024-03 | -5.39 | -2.46 | 2.93 | 54.36% |
| 2024-05-10 | 2024-03 | -5.39 | N/A | N/A | N/A |
| 2024-03-22 | 2023-12 | -10.94 | -8.33 | 2.61 | 23.86% |
Upgrade / Downgrade
| Date | Firm | Action | From | To |
|---|
Profile
Revelation Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of immune system therapeutics and diagnostics. It engages in developing therapeutic product candidates, including GEM-SSI, a potential therapy for the prevention and treatment of surgical sit infection; GEM-AKI, a potential therapy for the prevention and treatment of acute kidney injury; and GEM-CKD, a potential therapy for the prevention and treatment of chronic kidney disease. The company was founded in 2020 and is based in San Diego, California.
Insider Holder
| Date | Name | Relation | Quantity | Description |
|---|---|---|---|---|
| 2023-12-07 | TIDMARSH GEORGE F | Director | 42.10K | Sale |
Institution Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2024-09-29 | Sabby Management, LLC | 42.23K | 12.77K | 0.51% |
| 2024-09-29 | UBS Group AG | 40.95K | 12.38K | 0.49% |
| 2024-09-29 | Susquehanna International Group, LLP | 13.26K | 4.01K | 0.16% |
| 2024-09-29 | Tower Research Capital LLC (TRC) | 2.54K | 767.00 | 0.03% |
| 2024-09-29 | Pom Investment Strategies, LLC | 1.00 | 0.00 | 0.00% |
| 2024-09-29 | Bank of America Corporation | 29.00 | 8.00 | 0.00% |
Fund Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2024-10-30 | Fidelity Extended Market Index Fund | 8.02K | 2.42K | 0.10% |
| 2024-10-30 | Fidelity Series Total Market Index Fund | 2.94K | 889.00 | 0.04% |
| 2024-09-29 | Vanguard Extended Market Index Fund | 201.00 | 60.00 | 0.00% |
Split
| Split | Date |
|---|---|
| 1 : 4 | 2026-01-28 |
| 1 : 3 | 2025-07-07 |
| 1 : 16 | 2025-01-28 |
| 1 : 30 | 2024-01-25 |
| 1 : 35 | 2023-02-01 |